Thermo Fisher Scientific Inc.

05/02/2024 | Press release | Distributed by Public on 05/02/2024 14:11

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
1. Name and Address of Reporting Person *
Shafer Michael D
2. Date of Event Requiring Statement (Month/Day/Year)
2024-04-23
3. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [TMO]
(Last) (First) (Middle)
168 THIRD AVENUE
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
Executive Vice President /
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)
WALTHAM MA 02451
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Shafer Michael D
168 THIRD AVENUE

WALTHAM, MA02451


Executive Vice President

Signatures

/s/ Melodie T. Morin, Attorney-in-Fact for Michael D. Shafer 2024-05-02
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The options vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.
(2) The options vested in four equal annual installments on September 5, 2020, 2021, and 2022. The remaining one-quarter will vest on September 5, 2023.
(3) The options vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.
(4) The options vest in four equal annual installments. Three-quarters of the options vested on February 23, 2022, 2023, and 2024. The remaining one-quarter will vest on February 23, 2025.
(5) The options vest in four equal annual installments. Two-quarters of the options vested on February 28, 2023 and 2024, and the remaining two-quarters will vest on February 28, 2025 and 2026.
(6) The options vest in four equal annual installments. One-quarter of the options vested on February 28, 2024, and the remaining three-quarters will vest on February 28, 2025, 2026 and 2027.
(7) The options vest in four equal annual installments on February 28, 2025, 2026, 2027 and 2028.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.